Search Results
Found 292 results for "phase 2"
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |  Next >
www.lloyds.com/.../All_regulatory_communications/Solvency_II/Solvency_II_Whats_coming_up.htm
Market presentation excluding FSA slides
www.lloyds.com/.../0/MarketBriefingslidesforexternalcirculation_Nov2009.pdf
www.lloyds.com/.../NR/rdonlyres/0851FFCB-15DF-4C29-B259-A417BDDD5EDE/0/Guidancenotesfordryrunprocess.pdf
www.lloyds.com/.../23C5A7E7-89D2-41FB-8BA7-D1CB893BAE83/0/MarketBriefingagentslidesforcirculation.pdf
To advise the outcome of the market consultation regarding possible adoption of IFRS by the Lloyd s market
www.lloyds.com/NR/rdonlyres/7EFDFCAC-FA00-4C5A-A715-3594F65D995B/0/Y4085.pdf
FRANKFURT -(Dow Jones)- German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Thursday that a Phase II study showed its VEGF Trap-Eye treatment showed statistically significant improvement in vision in patients with diabetic macular edema....
www.lloyds.com/dj/DowJonesArticle.aspx?id=449868
www.lloyds.com/NR/rdonlyres/267AE5B5-594B-4F3B-9BB7-E3C76F3E419A/0/Y3698.pdf
www.lloyds.com/NR/rdonlyres/705059E1-2932-4C88-BCA1-6BAAB512A38C/0/Y3773.pdf
www.lloyds.com/NR/rdonlyres/CF7E48FC-0180-4369-9B07-7113C9DB6139/0/Y3741.pdf
Presentation given at the Lloyd's Investor Afternoon December 2006
www.lloyds.com/NR/rdonlyres/0A167156-56AA-4104-A04C-658102075719/0/InvestorAfternoon6Dec2006.pdf
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |  Next >
Powered by